Search

Your search keyword '"McAlpine, Jessica N."' showing total 674 results

Search Constraints

Start Over You searched for: Author "McAlpine, Jessica N." Remove constraint Author: "McAlpine, Jessica N."
674 results on '"McAlpine, Jessica N."'

Search Results

152. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics

153. Arginine depletion through ADI-PEG20 to treat argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type

154. Abstract GMM-020: CELL OF ORIGIN, MUTATION AND MICROENVIRONMENT: MODELING EARLY EVENTS OF ENDOMETRIOSIS ASSOCIATED CANCERS

155. Abstract GMM-030: MODELS AND ANALYTIC TECHNIQUES OF MULLERIAN TISSUE-DERIVED ORGANOIDS

157. Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers: Supplementary tables

158. Clear Cell and Endometrioid Carcinomas : are their differences attributable to distinct cells of origin?

159. Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers

162. Mismatch repair deficiency as a predictor of adjuvant radiotherapy response in endometrioid endometrial carcinoma.

164. Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers

166. HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

167. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.

170. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

172. Changing Clinical Practice

173. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

174. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

176. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome

177. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

178. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.

179. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53mutation status in ovarian mucinous tumors: implications for outcome analyses

180. The interface of malignant and immunologic clonal dynamics in high-grade serous ovarian cancer

181. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification

182. Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials

184. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

185. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor

186. Fluorescence confocal endomicroscopy of the cervix: pilot study on the potential and limitations for clinical implementation

187. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53null or missense mutational patterns

188. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53mutation status

189. Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test – Performance in a training and verification cohort

190. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.

197. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer

Catalog

Books, media, physical & digital resources